CAMP Signaling Prevents Podocyte Apoptosis Via Activation of Protein Kinase A and Mitochondrial Fusion

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Mar 20

PMID 24642777

Citations 15

Authors

Xiaoying Li

Hua Tao

Kewei Xie

Zhaohui Ni

Yucheng Yan

Kai Wei

Peter Y Chuang

John Cijiang He

Leyi Gu

Affiliations

Soon will be listed here.

Abstract

Our previous in vitro studies suggested that cyclic AMP (cAMP) signaling prevents adriamycin (ADR) and puromycin aminonucleoside (PAN)-induced apoptosis in podocytes. As cAMP is an important second messenger and plays a key role in cell proliferation, differentiation and cytoskeleton formation via protein kinase A (PKA) or exchange protein directly activated by cAMP (Epac) pathways, we sought to determine the role of PKA or Epac signaling in cAMP-mediated protection of podocytes. In the ADR nephrosis model, we found that forskolin, a selective activator of adenylate cyclase, attenuated albuminuria and improved the expression of podocyte marker WT-1. When podocytes were treated with pCPT-cAMP (a selective cAMP/PKA activator), PKA activation was increased in a time-dependent manner and prevented PAN-induced podocyte loss and caspase 3 activation, as well as a reduction in mitochondrial membrane potential. We found that PAN and ADR resulted in a decrease in Mfn1 expression and mitochondrial fission in podocytes. pCPT-cAMP restored Mfn1 expression in puromycin or ADR-treated podocytes and induced Drp1 phosphorylation, as well as mitochondrial fusion. Treating podocytes with arachidonic acid resulted in mitochondrial fission, podocyte loss and cleaved caspase 3 production. Arachidonic acid abolished the protective effects of pCPT-cAMP on PAN-treated podocytes. Mdivi, a mitochondrial division inhibitor, prevented PAN-induced cleaved caspase 3 production in podocytes. We conclude that activation of cAMP alleviated murine podocyte caused by ADR. PKA signaling resulted in mitochondrial fusion in podocytes, which at least partially mediated the effects of cAMP.

Citing Articles

METTL10 attenuates adriamycin-induced podocyte injury by targeting cell dedifferentiation.

Bao J, Li Z, Yao H, Wu B, Gu L, Pan Y Sci Rep. 2025; 15(1):1218.

PMID: 39774961 PMC: 11707283. DOI: 10.1038/s41598-024-80526-8.

Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis.

Li Y, Fan J, Zhu W, Niu Y, Wu M, Zhang A Kidney Dis (Basel). 2023; 9(4):254-264.

PMID: 37900001 PMC: 10601935. DOI: 10.1159/000530344.

Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.

Yamanaka M, Tamura Y, Kuribayashi-Okuma E, Uchida S, Shibata S Am J Physiol Renal Physiol. 2022; 324(2):F168-F178.

PMID: 36454699 PMC: 9844977. DOI: 10.1152/ajprenal.00144.2022.

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.

Lv Q, Han X, Ni J, Ma Q, Dai R, Liu J Cell Death Dis. 2022; 13(10):867.

PMID: 36229446 PMC: 9562403. DOI: 10.1038/s41419-022-05313-7.

Mechanisms of podocyte injury and implications for diabetic nephropathy.

Barutta F, Bellini S, Gruden G Clin Sci (Lond). 2022; 136(7):493-520.

PMID: 35415751 PMC: 9008595. DOI: 10.1042/CS20210625.

References

Kriz W, Gretz N, Lemley K . Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int. 1998; 54(3):687-97. DOI: 10.1046/j.1523-1755.1998.00044.x. View

Youle R, van der Bliek A . Mitochondrial fission, fusion, and stress. Science. 2012; 337(6098):1062-5. PMC: 4762028. DOI: 10.1126/science.1219855. View

Ronconi E, Sagrinati C, Angelotti M, Lazzeri E, Mazzinghi B, Ballerini L . Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2008; 20(2):322-32. PMC: 2637058. DOI: 10.1681/ASN.2008070709. View

Endlich N, Endlich K . cAMP pathway in podocytes. Microsc Res Tech. 2002; 57(4):228-31. DOI: 10.1002/jemt.10079. View

Kriz W, Hosser H, Hahnel B, Gretz N, Provoost A . From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant. 1998; 13(11):2781-98. DOI: 10.1093/ndt/13.11.2781. View

Qin Y, Stokman G, Yan K, Ramaiahgari S, Verbeek F, de Graauw M . cAMP signalling protects proximal tubular epithelial cells from cisplatin-induced apoptosis via activation of Epac. Br J Pharmacol. 2011; 165(4b):1137-50. PMC: 3346244. DOI: 10.1111/j.1476-5381.2011.01594.x. View

Susztak K, Raff A, Schiffer M, Bottinger E . Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2005; 55(1):225-33. View

Prodromidi E, Poulsom R, Jeffery R, Roufosse C, Pollard P, Pusey C . Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells. 2006; 24(11):2448-55. DOI: 10.1634/stemcells.2006-0201. View

Gao S, Li C, Shimokawa T, Terashita T, Matsuda S, Yaoita E . Rho-family small GTPases are involved in forskolin-induced cell-cell contact formation of renal glomerular podocytes in vitro. Cell Tissue Res. 2007; 328(2):391-400. DOI: 10.1007/s00441-006-0365-3. View

10.

Pavenstadt H, Kriz W, Kretzler M . Cell biology of the glomerular podocyte. Physiol Rev. 2002; 83(1):253-307. DOI: 10.1152/physrev.00020.2002. View

11.

Youle R, Karbowski M . Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol. 2005; 6(8):657-63. DOI: 10.1038/nrm1697. View

12.

Stokman G, Qin Y, Genieser H, Schwede F, de Heer E, Bos J . Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure. J Am Soc Nephrol. 2011; 22(5):859-72. PMC: 3083308. DOI: 10.1681/ASN.2010040423. View

13.

Martinou J, Green D . Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol. 2001; 2(1):63-7. DOI: 10.1038/35048069. View

14.

Ruster C, Franke S, Wenzel U, Schmidthaupt R, Fraune C, Krebs C . Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction. Am J Nephrol. 2011; 34(4):309-17. DOI: 10.1159/000329321. View

15.

Gu L, Dai Y, Xu J, Mallipattu S, Kaufman L, Klotman P . Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS. 2013; 27(7):1091-8. PMC: 3918880. DOI: 10.1097/QAD.0b013e32835f1ea1. View

16.

Johnstone D, Holzman L . Clinical impact of research on the podocyte slit diaphragm. Nat Clin Pract Nephrol. 2006; 2(5):271-82. DOI: 10.1038/ncpneph0180. View

17.

Schiffer M, Bitzer M, Roberts I, Kopp J, Ten Dijke P, Mundel P . Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest. 2001; 108(6):807-16. PMC: 200928. DOI: 10.1172/JCI12367. View

18.

Shen B, Kwan H, Ma X, Wong C, Du J, Huang Y . cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway. J Biol Chem. 2011; 286(22):19439-45. PMC: 3103323. DOI: 10.1074/jbc.M110.210294. View

19.

Cartoni R, Leger B, Hock M, Praz M, Crettenand A, Pich S . Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005; 567(Pt 1):349-58. PMC: 1474174. DOI: 10.1113/jphysiol.2005.092031. View

20.

Petermann A, Krofft R, Blonski M, Hiromura K, Vaughn M, Pichler R . Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int. 2003; 64(4):1222-31. DOI: 10.1046/j.1523-1755.2003.00217.x. View